Assignee
CHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD
CN·4 granted patents·7 pending applications·2 citations·filing 2017–2022
Top patents by PatentIndex Score
11 records- 0179US11155632B2Anti-CD47 monoclonal antibody and use thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2017·Granted Oct 26, 2021·2 cites·11 claims
- 0260US12344669B2Anti-CD47 monoclonal antibody and use thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2021·Granted Jul 1, 2025·0 cites·14 claims
- 0355US2024190875A1Spiroindoline derivative, and preparation method and medical use thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0451US2024228501A1Imidazole-containing condensed ring derivative, preparation method therefor, and application thereof in medicineCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0546US12258386B2Humanized anti-A β monoclonal antibody and application thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 25, 2025·0 cites·9 claims
- 0646US2022073620A1Antibody fusion protein, preparation method therefor and application thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 0745US2022242936A1Humanized anti-a[beta] monoclonal antibody and application thereofCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0844US12404326B2Bivalent bispecific antibody and preparation method thereof, coding gene, host cell and compositionCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2019·Granted Sep 2, 2025·0 cites·8 claims
- 0941US2023390275A1Application of ester group-containing aromatic propionamide compound and metabolite thereof in preparation of drug for treating heart failureCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1041US2023355567A1Application of ester group-containing aromatic propionamide compounds in preparation of drugs for treating urinary incontinenceCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1141US2023364047A1Use of ester group-containing aromatic propionamide compound in preparation of medicine for treating dry eye syndromeCHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →